Some of the PD-related susceptibility genes have been also associated with levodopa-induced motor complications in PD patients; for instance, polymorphisms in MAO-B and COMT genes have been shown to increase the risk of developing dyskinesias and wearing-off [143]. This evidence concerns the gene MAOB and drug-induced dyskinesia.